-
Snibe SARS-COV-2 tests accurately detect Omicron variant
Based on assessment of sequences and bioinformatics analysis, we confirm that Snibe’s assays for detection of the SARS-CoV-2 virus in the table below are effective in detecting SARS-CoV-2 variants reported by WHO including B.1.1.529 (Omicron), B.1.1.7 (Alpha), B.1.351 (Beta), P.1 (Gamma), B.1.617.2 (Delta), C.37 (Lambda), B.1.617.1 (Kappa), etc. -
Snibe launched MAGLUMI? SARS-CoV-2 Neutralizing Antibody
Neutralizing Antibody Assay from Snibe is available in CE accepting areas! -
Snibe announced a global strategic cooperation with Thermo Fisher Scientific
From August 29th to 31st, 2019, the 15th National Congress of Laboratory Medicine (NCLM 2019), hosted by Chinese Medical Association and Chinese Society of Laboratory Medicine, was held at Suzhou International Expo Centre.
-
Snibe Showcases Total Lab Automation at MEDLAB 2020
From Feb. 3rd to 6th, Snibe brings the latest product SATLAS-TCA to Medlab Middle East with booth NO.: Z5.C20. in Dubai, United Arab Emirates, one of the largest and most influential medical exhibitions across the world, attracting more than 25,800 professional visitors, providing a great platform for all to share and communicate the recent technology available in the IVD, and medical laboratory market. -
Snibe Shines at Medica 2019
Medica, known as the world's largest trade fair for medical technology, was held in Dusseldorf, Germany, from November 18th to 21st. -
Snibe Shows Great Charms at 71th AACC
Snibe brings the latest innovation MAGLUMI X8 to 71st AACC Annual Scientific Meeting & Clinical Lab Expo, with booth No. 1317 in California United States, one of the largest and most influential medical exhibitions across the world, attracting more than 21,000 visitors, and 800 exhibitors dedicated to sharing the most advanced technology available in the IVD, and medical laboratory market.
